[Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii]
- PMID: 20098782
[Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii]
Abstract
Bacterial multi-drugs systems contribute to the development of multi-resistance patterns of Acinetobacter baumannii, a nosocomial pathogen of increasing importance due to its emerging resistance to carbapenems. The multi-resistance phenomena is generated by a combination of mechanisms, one of which the efflux pump system. Many of these multiresistant isolates of A. baumannii harbor genes for the AdeABC multi-drug efflux system, related with resistance to various groups of antibacterial agents, including tygecicline and meropenem. Inhibition of these systems would allow to increase the efficacy of this antimicrobial. This review focuses on the multi-drug efflux pump system of A. baumannii with special emphasis in the AdeABC system.
Similar articles
-
Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex.Int J Antimicrob Agents. 2009 Jan;33(1):27-32. doi: 10.1016/j.ijantimicag.2008.06.027. Epub 2008 Sep 13. Int J Antimicrob Agents. 2009. PMID: 18790612
-
Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.Diagn Microbiol Infect Dis. 2008 Nov;62(3):326-32. doi: 10.1016/j.diagmicrobio.2008.06.008. Epub 2008 Aug 8. Diagn Microbiol Infect Dis. 2008. PMID: 18687557
-
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.J Antimicrob Chemother. 2007 Jun;59(6):1210-5. doi: 10.1093/jac/dkl509. Epub 2007 Feb 26. J Antimicrob Chemother. 2007. PMID: 17324960 Review.
-
Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.Folia Histochem Cytobiol. 2008;46(3):257-67. doi: 10.2478/v10042-008-0056-x. Folia Histochem Cytobiol. 2008. PMID: 19056528 Review.
-
AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.J Antimicrob Chemother. 2007 May;59(5):1001-4. doi: 10.1093/jac/dkm058. Epub 2007 Mar 15. J Antimicrob Chemother. 2007. PMID: 17363424
Cited by
-
First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt.New Microbes New Infect. 2018 Aug 24;26:53-58. doi: 10.1016/j.nmni.2018.08.007. eCollection 2018 Nov. New Microbes New Infect. 2018. PMID: 30224972 Free PMC article.
-
Subinhibitory Concentrations of Clinically-Relevant Antimicrobials Affect Resistance-Nodulation-Division Family Promoter Activity in Acinetobacter baumannii.Front Microbiol. 2021 Dec 3;12:780201. doi: 10.3389/fmicb.2021.780201. eCollection 2021. Front Microbiol. 2021. PMID: 34925284 Free PMC article.
-
Glycyrrhetinic acid protects against Multidrug-resistant Acinetobacter baumannii-induced lung epithelial cells injury by regulating inflammation and oxidative stress.BMC Pharmacol Toxicol. 2023 Jan 30;24(1):5. doi: 10.1186/s40360-023-00648-z. BMC Pharmacol Toxicol. 2023. PMID: 36717837 Free PMC article.
-
Acinetobacter baumannii: an evolving and cunning opponent.Front Microbiol. 2024 Jan 22;15:1332108. doi: 10.3389/fmicb.2024.1332108. eCollection 2024. Front Microbiol. 2024. PMID: 38318341 Free PMC article. Review.
-
Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat.Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1009-1019. doi: 10.1007/s10096-018-3223-9. Epub 2018 Mar 9. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29524060 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical